Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Flu drug demand could `swamp GPs'

John von Radowitz
Friday 02 July 1999 19:02 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

A NEW generation of drugs to combat influenza could result in GP surgeries being hopelessly swamped by patients, doctors warned yesterday.

The first of the drugs, Relenza, has just been licensed for use in the UK and should be available soon. Relenza does not cure the illness but it reduces symptoms and shortens their duration by about two and a half days.

But Dr John Chisholm, chairman of the the British Medical Association's general practitioners' committee, said: "The launch of these drugs will potentially lead to enormous patient demand and huge additional pressures on GPs and primary care services and budgets.

"If those demands were to coincide with the Christmas and Millennium holiday, the NHS could be dangerously overstretched and the contingency plans which are rightly being devised in local winter planning groups may fail to meet the need."

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in